Ancient Herbal Therapy may protect heart from hypertrophy: Study
Mahesh Gupta, an american scientist of Indian Origin through a study has claimed that ancient herbal therapy can protect the heart from hypertrophy.
Hypertrophy is a thickening of cardiac muscle often caused by chronic high blood pressure that can lead to heart failure.
Gupta, director of the Cardiac Cell Biology Research Program at University of Chicago and study's author, said that they found the natural compound, honokiol, derived from the bark of the magnolia tree activates SIRT3, a protective protein associated with delayed aging, stress resistance and metabolic regulation.
When injected into mice, it reduced the excess growth of individual cardiac muscle cells, decreased ventricular wall thickness and prevented the accumulation of interstitial fibrosis, a stiffening of cardiac muscle cells that reduces their ability to contract. It also protected heart muscle cells from the damage caused by oxidative stress, which can damage DNA.
It even mitigated pre-existing cardiac hypertrophy, he added.
The results, the authors wrote, suggest pharmacological activation of SIRT3 by honokiol could be "a potential therapeutic strategy to prevent adverse cardiac remodeling and other diseases associated with abnormal cellular growth and organ fibrosis."
Gupta said that they were working to design a clinical trial involving patients with cardiac hypertrophy and potentially other metabolic diseases, such as type 2 diabetes.
The study is reported in the online journal Nature Communications.(ANI)
Hypertrophy is a thickening of cardiac muscle often caused by chronic high blood pressure that can lead to heart failure.
Gupta, director of the Cardiac Cell Biology Research Program at University of Chicago and study's author, said that they found the natural compound, honokiol, derived from the bark of the magnolia tree activates SIRT3, a protective protein associated with delayed aging, stress resistance and metabolic regulation.
When injected into mice, it reduced the excess growth of individual cardiac muscle cells, decreased ventricular wall thickness and prevented the accumulation of interstitial fibrosis, a stiffening of cardiac muscle cells that reduces their ability to contract. It also protected heart muscle cells from the damage caused by oxidative stress, which can damage DNA.
It even mitigated pre-existing cardiac hypertrophy, he added.
The results, the authors wrote, suggest pharmacological activation of SIRT3 by honokiol could be "a potential therapeutic strategy to prevent adverse cardiac remodeling and other diseases associated with abnormal cellular growth and organ fibrosis."
Gupta said that they were working to design a clinical trial involving patients with cardiac hypertrophy and potentially other metabolic diseases, such as type 2 diabetes.
The study is reported in the online journal Nature Communications.(ANI)
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.